1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Foot and Mouth Disease (FMD) Vaccine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Animal Type
6.1 Cattle
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Pig
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Sheep and Goat
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Vaccine Type
7.1 Conventional Vaccines
7.1.1 Market Trends
7.1.2 Oil-Based Vaccines
7.1.2.1 Market Trends
7.1.2.2 Market Forecast
7.1.3 Aluminum hydroxide/saponin-based Vaccines
7.1.3.1 Market Trends
7.1.3.2 Market Forecast
7.1.4 Market Forecast
7.2 Emergency Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Government Organizations
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Distributors/Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Private Vet
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 Asia Pacific
9.1.1 China
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 India
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.1.3 Bangladesh
9.1.3.1 Market Trends
9.1.3.2 Market Forecast
9.1.4 Vietnam
9.1.4.1 Market Trends
9.1.4.2 Market Forecast
9.1.5 Korea
9.1.5.1 Market Trends
9.1.5.2 Market Forecast
9.1.6 Others
9.1.6.1 Market Trends
9.1.6.2 Market Forecast
9.2 Latin America
9.2.1 Brazil
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Argentina
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 Others
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.3 Middle East and Africa
9.3.1 Nigeria
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 Ethiopia
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 Iran
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Algeria
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Others
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.4 Europe
9.4.1 Turkey
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Georgia
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Armenia
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porter’s Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Paramount Agrovet Pvt. Ltd.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Biogénesis Bagó
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Boehringer Ingelheim International GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Brilliant Bio Pharma Private Limited
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 China Animal Husbandry Group
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 FGBI “Federal Center for Animal Health”
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Indian Immunologicals Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Limor de Colombia
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Merck & Co. Inc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Vecol S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Vetal Animal Health Products Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/